High PD-L1 expression, which tumors use as a key mechanism to evade the immune system, indicates a potential role for ICIs, such as anti-PD-1 or anti-PD-L1 antibodies, in treating LAC-TB. The gene discussed is CD274; the disease is tuberculosis.